Pharma News India

The Indian pharmaceutical industry is growing at a very fast pace. With its fast growth, it is highly imperative to stay updated with the current news and trends in the market. Brand India Pharma gives you the latest pharmacy related news to help you stay updated. Read the latest pharmaceutical news about different sectors and their strategies in the Indian Pharma News section. Get fresh updates from Pharma companies like Natco, Panacea Biotec, Hamsons.
You can bookmark the Indian Pharma News section for the news on pharmaceuticals, drugs and formulations. The Brand India pharmacy news also includes pharmaceutical conference highlights for inquisitive readers.

Testing of 42,000 samples of Indian drugs for quality would be completed in the next six to eight months as part of a mega survey, stated by Dr G N Singh, Drugs Controller General of India (DCGI).

May 29, 2015: "After about six months, we will actually know and tell the world that our drugs are of quality. This will also help negate misnomers as various numbers are being circulate...


The country is planning to set up a global alert system, with the mechanism where a drug regulator from any country could report on unfair practices adopted by Indian pharma firms.

May 26, 2015: The step comes close on the heel of recent reports of Indian pharma firms involved in unfair practises like manipulation of USFDA rules. "We have planned an international alert system an...


The company aims to focus majorly on two therapeutic areas of dermatology and respiratory

Mumbai, April 20, 2015: The Indian pharma company Lupin plans to focus on two therapeutic areas of dermatology and respiratory and is expecting close to 25-30 product approvals in FY16, according to a report by Barclays Equity Research.


The plant is expected to go on stream by the end of the year.

New Delhi, April 7, 2015: Mankind Pharma is planning to invest close to Rs100 crore in setting up active pharmaceutical ingredients (API) facility in Rajasthan, which is expected to go on stream by the end of the year.


The company has launched its Amlodipine and Valsartan tablets in the US market.

New Delhi, April 1, 2015: Lupin has launched its Amlodipine and Valsartan tablets, used for the treatment of hypertension, in the US market. The company said in a statement that its US arm, Lupin Pharmaceuticals Inc has launched Amlodipine and Valsartan in various strengths in the US market after sec...


Comment!
 
 






* Indicates mandatory field.
Please wait while comments are being sent...